Management of refractory dyspnoea in COPD Source: Virtual Congress 2021 – Highlights from the JAMA Network on idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease and lung cancer screening Year: 2021
Sertraline effects on dyspnea in patients with severe COPD Source: Eur Respir J 2005; 26: Suppl. 49, 288s Year: 2005
Opioid prescription for severe chronic breathlessness to hospitalised patients with COPD - a clinical audit Source: Virtual Congress 2020 – Clinical data and COPD management Year: 2020
Fentanyl nasal spray in a patient with end-stage COPD and severe chronic breathlessness Source: Breathe, 15 (3) e122; 10.1183/20734735.0183-2019 Year: 2019
Is nebulized morphine effective in treating persistent dyspnea in very severe COPD? A preliminary report Source: International Congress 2015 – Latest insights into the management of chronic respiratory diseases Year: 2015
Impact of exacerbation of COPD on anxiety and depression symptoms and dyspnea in the activities of daily living Source: International Congress 2015 – Rehabilitation, exercise, hospitalisation and COPD Year: 2015
Are COPD patients with chronic dyspnea and attending pulmonary rehabilitation treated with dual bronchodilatation or not? Source: International Congress 2016 – Best abstracts in COPD management Year: 2016
Attitudes of patients with chronic breathlessness towards treatment with opioids Source: Eur Respir J, 55 (2) 1901752; 10.1183/13993003.01752-2019 Year: 2020
A targeted intervention for depression initiated during pulmonary rehabilitation improves adherence to exercise, mood and dyspnea after acute exacerbation of COPD (AECOPD) Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation Year: 2013
Safety in treating dyspnea with morphine in ILD patients Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias? Year: 2018
Exacerbation of respiratory symptoms in COPD patients may not be exacerbations of COPD Source: Eur Respir J 2013; 41: 993-995 Year: 2013
Assessing COPD profiles and outcomes by dyspnoea severity Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016
Exertional dyspnea relief following bronchodilation in COPD: Role of neural respiratory drive Source: International Congress 2015 – Clinical physiology: from airways, lung and respiratory muscles to dyspnoea in health and disease Year: 2015
Evaluation of nasal optiflow device in management of COPD patients in acute exacerbations Source: International Congress 2015 – Acute critical care: COPD, muscles and weaning Year: 2015
Evaluation of physical sings and symptoms in patients with acute exacerbation of COPD Source: Annual Congress 2008 - Prognosis in COPD Year: 2008
Repercussion of cough in sleep quality in COPD exacerbation Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD Year: 2014
Dyspnea sensation and health-related quality predict exacerbations, hospitalizations and mortality in patients with chronic respiratory failure receiving long-term oxygen therapy Source: Eur Respir J 2006; 28: Suppl. 50, 519s Year: 2006
Clinical effectiveness of antidepressive drug in patients with COPD and concomitant moderate depressive episode Source: Annual Congress 2013 –COPD treatment and others Year: 2013
Impact of pulmonary rehabilitation on cough and sputum symptom perception in patients with COPD Source: International Congress 2015 – Latest insights into pulmonary rehabilitation Year: 2015
Overdiagnosis of COPD and asthma among elderly with chronic dyspnea Source: Virtual Congress 2021 – Primary care diagnosis and multimorbidities Year: 2021